3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Julphar Gulf Pharmaceutical Industries: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal Julphar Insulin N (human isophane insulin), Huminsulin® Basal (NPH, human isophane insulin) - Diabetes Mellitus | Phase 1 | Completed | Julphar Gulf Pharmaceutical Industries | 85 | 2016-11-16 | 2020-07-02 |
| Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III human biphasic insulin, human biphasic insulin, reference - Diabetes Mellitus | Phase 1 | Completed | Julphar Gulf Pharmaceutical Industries | 73 | 2016-02-01 | 2016-08-02 |
| Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal Julphar Insulin R (soluble human insulin, biosimilar), Huminsulin® Normal (soluble human insulin, reference) - Diabetes Mellitus | Phase 1 | Completed | Julphar Gulf Pharmaceutical Industries | 26 | 2014-12-01 | 2015-12-24 |
Biosimilar Pharmaceuticals (1) · Isophane Insulin, Human (1) · biphasic human insulin 30 (1)
Germany (3)
Tim Heise, MD (1)
2015 (1), 2016 (1)